Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases

Virus Res. 2023 Oct 2:335:199191. doi: 10.1016/j.virusres.2023.199191. Epub 2023 Aug 4.

Abstract

The Ubiquitin-protein ligase E3A, UBE3A, also known as E6-associated protein (E6-AP), is known to play an essential role in regulating the degradation of various proteins by transferring Ub from E2 Ub conjugating enzymes to the substrate proteins. Several studies indicate that UBE3A regulates the stabilities of key viral proteins in the virus-infected cells and, thereby, the infected virus-mediated diseases, even if it were reported that UBE3A participates in non-viral-related human diseases. Furthermore, mutations such as deletions and duplications in the maternally inherited gene in the brain cause human neurodevelopmental disorders such as Angelman syndrome (AS) and autism. It is also known that UBE3A functions as a transcriptional coactivator for the expression of steroid hormone receptors. These reports establish that UBE3A is distinguished by its multitudinous functions that are paramount to viral pathology and human diseases. This review is focused on molecular mechanisms for such intensive participation of UBE3A in disease formation and virus regulation.

Keywords: E6-AP; HCV; HIV-1; HPV; UBE3A; Ubiquitin; Ubiquitin Proteasome System (UPS).

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Angelman Syndrome* / genetics
  • Angelman Syndrome* / metabolism
  • Angelman Syndrome* / pathology
  • Brain / pathology
  • Humans
  • Mutation
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • Virus Diseases* / genetics

Substances

  • Ubiquitin-Protein Ligases
  • UBE3A protein, human